GURUFOCUS.COM » STOCK LIST » Healthcare » Drug Manufacturers » Tchaikapharma Highquality Medicines AD (XBUL:THQM) » Definitions » EBITDA Margin %

Tchaikapharma Highquality Medicines AD (XBUL:THQM) EBITDA Margin % : 17.96% (As of Mar. 2024)


View and export this data going back to 2012. Start your Free Trial

What is Tchaikapharma Highquality Medicines AD EBITDA Margin %?

EBITDA Margin % is calculated as EBITDA divided by its Revenue. Tchaikapharma Highquality Medicines AD's EBITDA for the three months ended in Mar. 2024 was лв2.40 Mil. Tchaikapharma Highquality Medicines AD's Revenue for the three months ended in Mar. 2024 was лв13.36 Mil. Therefore, Tchaikapharma Highquality Medicines AD's EBITDA margin for the quarter that ended in Mar. 2024 was 17.96%.


Tchaikapharma Highquality Medicines AD EBITDA Margin % Historical Data

The historical data trend for Tchaikapharma Highquality Medicines AD's EBITDA Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

* Premium members only.

Tchaikapharma Highquality Medicines AD EBITDA Margin % Chart

Tchaikapharma Highquality Medicines AD Annual Data
Trend Dec16 Dec17 Dec18 Dec19 Dec20 Dec21 Dec22 Dec23
EBITDA Margin %
Get a 7-Day Free Trial 19.34 12.74 13.42 15.91 14.87

Tchaikapharma Highquality Medicines AD Quarterly Data
Jun19 Sep19 Dec19 Mar20 Jun20 Sep20 Dec20 Mar21 Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24
EBITDA Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 22.48 26.73 7.73 -1.23 17.96

Competitive Comparison of Tchaikapharma Highquality Medicines AD's EBITDA Margin %

For the Drug Manufacturers - Specialty & Generic subindustry, Tchaikapharma Highquality Medicines AD's EBITDA Margin %, along with its competitors' market caps and EBITDA Margin % data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Tchaikapharma Highquality Medicines AD's EBITDA Margin % Distribution in the Drug Manufacturers Industry

For the Drug Manufacturers industry and Healthcare sector, Tchaikapharma Highquality Medicines AD's EBITDA Margin % distribution charts can be found below:

* The bar in red indicates where Tchaikapharma Highquality Medicines AD's EBITDA Margin % falls into.



Tchaikapharma Highquality Medicines AD EBITDA Margin % Calculation

EBITDA margin is the ratio of EBITDA divided by net sales or Revenue, usually presented in percent.

Tchaikapharma Highquality Medicines AD's EBITDA Margin % for the fiscal year that ended in Dec. 2023 is calculated as

EBITDA Margin %=EBITDA (A: Dec. 2023 )/Revenue (A: Dec. 2023 )
=7.226/48.586
=14.87 %

Tchaikapharma Highquality Medicines AD's EBITDA Margin % for the quarter that ended in Mar. 2024 is calculated as

EBITDA Margin %=EBITDA (Q: Mar. 2024 )/Revenue (Q: Mar. 2024 )
=2.399/13.361
=17.96 %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.


Tchaikapharma Highquality Medicines AD  (XBUL:THQM) EBITDA Margin % Explanation

EBITDA Margin % is the ratio of EBITDA divided by net sales or Revenue. It is an performance metric measuring company's operating profitability. EBITDA Margin takes depreciation and amortization, interest expense and tax into account, which makes it easy to compare the relative profitability of companies of different sizes in the same industry.


Tchaikapharma Highquality Medicines AD EBITDA Margin % Related Terms

Thank you for viewing the detailed overview of Tchaikapharma Highquality Medicines AD's EBITDA Margin % provided by GuruFocus.com. Please click on the following links to see related term pages.


Tchaikapharma Highquality Medicines AD (XBUL:THQM) Business Description

Traded in Other Exchanges
N/A
Address
1 G. M. Dimitrov Boulevard, Sofia, BGR, 1172
Tchaikapharma Highquality Medicines AD is engaged in the business of manufacturing and selling pharmaceuticals in Bulgaria. It manufactures medicines for cancer, heart diseases, respiratory problems, and neurological diseases, among others.

Tchaikapharma Highquality Medicines AD (XBUL:THQM) Headlines

No Headlines